Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Standard of Care Therapies for Treatment of Stage 4 Non-small Cell Lung Cancer (NSCLC) Following Platinum Failure (LUNAR)
NovoCure Ltd.
NovoCure Ltd.
Eastern Cooperative Oncology Group
Spanish Breast Cancer Research Group
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Baylor College of Medicine
Hoffmann-La Roche
Mayo Clinic
Daiichi Sankyo
Janssen Research & Development, LLC
Bristol-Myers Squibb
Wake Forest University Health Sciences
The Methodist Hospital Research Institute
University of Chicago
University of Michigan Rogel Cancer Center
Astellas Pharma Inc
Bristol-Myers Squibb
BeOne Medicines
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Ottawa Hospital Research Institute
Merck Sharp & Dohme LLC
Hoffmann-La Roche
Gilead Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mayo Clinic
Jonsson Comprehensive Cancer Center
Dana-Farber Cancer Institute
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
M.D. Anderson Cancer Center
Mirati Therapeutics Inc.
National Cancer Institute (NCI)
Bristol-Myers Squibb
Amgen
Merck Sharp & Dohme LLC
Sanofi
National Cancer Institute (NCI)
Sanofi
GERCOR - Multidisciplinary Oncology Cooperative Group
Trishula Therapeutics, Inc.
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
GlaxoSmithKline
BeiGene
Bristol-Myers Squibb